Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Other Working Capital Changes (2023 - 2025)

Immunocore Holdings' Other Working Capital Changes history spans 3 years, with the latest figure at $1.0 million for Q4 2025.

  • For Q4 2025, Other Working Capital Changes rose 113.44% year-over-year to $1.0 million; the TTM value through Dec 2025 reached $6.7 million, up 508.98%, while the annual FY2025 figure was $6.7 million, 508.98% up from the prior year.
  • Other Working Capital Changes for Q4 2025 was $1.0 million at Immunocore Holdings, down from $6.1 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $21.7 million in Q2 2023 and bottomed at -$18.1 million in Q1 2023.
  • The 3-year median for Other Working Capital Changes is -$182500.0 (2025), against an average of -$287666.7.
  • The largest YoY upside for Other Working Capital Changes was 161.68% in 2024 against a maximum downside of 198.26% in 2024.
  • A 3-year view of Other Working Capital Changes shows it stood at -$2.5 million in 2023, then plummeted by 198.26% to -$7.6 million in 2024, then soared by 113.44% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for IMCR's Other Working Capital Changes are $1.0 million (Q4 2025), $6.1 million (Q3 2025), and -$393000.0 (Q2 2025).